ClearPoint Neuro Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
ClearPoint Neuro has a total shareholder equity of $32.1M and total debt of $10.0M, which brings its debt-to-equity ratio to 31.1%. Its total assets and total liabilities are $52.6M and $20.4M respectively.
Anahtar bilgiler
31.1%
Borç/özkaynak oranı
US$9.98m
Borç
| Faiz karşılama oranı | n/a |
| Nakit | US$32.85m |
| Eşitlik | US$32.13m |
| Toplam yükümlülükler | US$20.44m |
| Toplam varlıklar | US$52.57m |
Son finansal sağlık güncellemeleri
Is ClearPoint Neuro (NASDAQ:CLPT) Weighed On By Its Debt Load?
Aug 16
Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?
Dec 06Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?
Aug 18Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?
Jan 03ClearPoint Neuro (NASDAQ:CLPT) Has Debt But No Earnings; Should You Worry?
Aug 18Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?
Apr 25Recent updates
Investors Appear Satisfied With ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Prospects As Shares Rocket 28%
Sep 14Is ClearPoint Neuro (NASDAQ:CLPT) Weighed On By Its Debt Load?
Aug 16Investors Appear Satisfied With ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Prospects As Shares Rocket 26%
Jul 11ClearPoint Neuro, Inc. (NASDAQ:CLPT) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
May 09ClearPoint Neuro: Macro-Induced Multiple Compression
Apr 25Are ClearPoint Neuro, Inc. (NASDAQ:CLPT) Investors Paying Above The Intrinsic Value?
Apr 19Analysts Have Made A Financial Statement On ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Yearly Report
Mar 15Should You Investigate ClearPoint Neuro, Inc. (NASDAQ:CLPT) At US$6.18?
Jan 04Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?
Dec 06Is There An Opportunity With ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) 41% Undervaluation?
Nov 06Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?
Aug 18ClearPoint Neuro, Inc. (NASDAQ:CLPT) Looks Just Right With A 40% Price Jump
Apr 17Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?
Jan 03ClearPoint Neuro: Continuous Great Execution
Sep 19ClearPoint Neuro: Picks & Shovels Galore
Aug 19ClearPoint Neuro (NASDAQ:CLPT) Has Debt But No Earnings; Should You Worry?
Aug 18ClearPoint Neuro: A 'Picks And Shovels' Biotech Company
Jul 25ClearPoint Neuro: Continuous Execution Despite Covid Headwind
May 20Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?
Apr 25ClearPoint Neuro: A Strong Recovery Play Once COVID Subsides
Mar 18Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: CLPT's short term assets ($46.6M) exceed its short term liabilities ($16.7M).
Uzun Vadeli Yükümlülükler: CLPT's short term assets ($46.6M) exceed its long term liabilities ($3.7M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: CLPT has more cash than its total debt.
Borcun Azaltılması: CLPT's debt to equity ratio has increased from 27.1% to 31.1% over the past 5 years.
Bilanço
Nakit Pist Analizi
Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.
İstikrarlı Nakit Pisti: CLPT has sufficient cash runway for more than 3 years based on its current free cash flow.
Tahmini Nakit Akışı: CLPT has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 24.2% each year